Cargando…
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Dendritic cells (DCs) are key orchestrators of immune responses. A specific DC subset, conventional type 1 DCs (cDC1s), has been recently associated with human cancer patient survival and, in preclinical models, is critical for the spontaneous rejection of immunogenic cancers and for the success of...
Autores principales: | Böttcher, Jan P., Reis e Sousa, Caetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207145/ https://www.ncbi.nlm.nih.gov/pubmed/30352680 http://dx.doi.org/10.1016/j.trecan.2018.09.001 |
Ejemplares similares
-
Oncogenic Transformation of Dendritic Cells and Their Precursors Leads to Rapid Cancer Development in Mice
por: Böttcher, Jan P., et al.
Publicado: (2015) -
Conventional type 1 dendritic cells (cDC1) in cancer immunity
por: Liu, Peng, et al.
Publicado: (2023) -
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
por: Calmeiro, João, et al.
Publicado: (2020) -
The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity
por: Saito, Yasuyuki, et al.
Publicado: (2022) -
Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis
por: Sasaki, Izumi, et al.
Publicado: (2022)